, extrahepatic spread, and macrovascular invasion. Variables chosen in the logistic and Cox models were based on their possible correlation with opioid intake and the possible relationship to outcomes in this patient cohort. Results Patient Characteristics A
Search Results
Omar Abdel-Rahman, Hatim Karachiwala, and Jacob C. Easaw
David E. Gerber, Thomas Y. Sheffield, M. Shaalan Beg, Erin L. Williams, Valerie L. Clark, Yang Xie, M.E. Blair Holbein, Celette Sugg Skinner, and Simon J. Craddock Lee
applying the Fisher exact test to contingency tables. Results A total of 94 of 108 (87%) survey recipients completed the survey. Characteristics of these individuals are shown in Table 1 . As would be expected given the high response rate, there
Neal Andruska, Benjamin W. Fischer-Valuck, Ruben Carmona, Temitope Agabalogun, Randall J. Brenneman, Hiram A. Gay, Jeff M. Michalski, and Brian C. Baumann
,559 (61%) received LDR-BT, 432 (7%) received HDR-BT, and 1,847 (32%) received BT not otherwise specified. Baseline characteristics among men stratified by treatment with EBRT or BT are summarized in Table 1 . The average age of men receiving EBRT versus
Anthony A. Matthews, Sharon Peacock Hinton, Susannah Stanway, Alexander R. Lyon, Liam Smeeth, Krishnan Bhaskaran, and Jennifer L. Lund
generally small. Table 1. Baseline Characteristics of Study Cohorts Primary Analyses Mean follow-up per person ranged from 3.73 years in the valvular heart disease analysis to 4.50 years in the pulmonary embolism analysis. Incident rates of cardiovascular
Yoshikuni Kawaguchi, Scott Kopetz, Heather A. Lillemoe, Hyunsoo Hwang, Xuemei Wang, Ching-Wei D. Tzeng, Yun Shin Chun, Thomas A. Aloia, and Jean-Nicolas Vauthey
1998 through October 2011 were included in the analysis ( supplemental eFigure 1 , available with this article at JNCCN.org ). Table 1 shows the demographic and clinicopathologic characteristics for all 1,221 patients and the 427 patients who had
Pamala A. Pawloski, Cara L. McDermott, James H. Marshall, Vanita Pindolia, Catherine M. Lockhart, Catherine A. Panozzo, Jeffrey S. Brown, and Bernadette Eichelberger
curation process. 44 , 45 Table 2. Frequency of FN Hospitalizations and AEs in Patients Who Received G-CSF Prophylaxis for First-Line Therapy of Breast or Lung Cancer a Results Baseline Characteristics We identified 38,721 unique
Chetna Malhotra, Rahul Malhotra, Filipinas Bundoc, Irene Teo, Semra Ozdemir, Noreen Chan, and Eric Finkelstein
) predominantly spiritual suffering, (4) rapidly increasing suffering, and (5) persistently high suffering ( Figure 1 ). Table 1. Patient Characteristics Figure 1. Trajectories of psychological, spiritual, physical, and functional suffering during
Michael Koehler, Susanne Hoppe, Siegfried Kropf, Anke Lux, Rainer Bartsch, Bernhard Holzner, Juergen Krauter, Axel Florschütz, Kathleen Jentsch-Ullrich, Joerg Frommer, Hans-Henning Flechtner, and Thomas Fischer
noncompleters had a distress score >3; chi-square, P =.049). Abbreviations: T0, baseline; T1, pretreatment; T2, posttreatment; T3, follow-up. Patient- and disease-related characteristics were distributed equally between the study groups ( Tables 2 and 3
Michael P. Douglas, Stacy W. Gray, and Kathryn A. Phillips
. Characteristics of 2019 Positive Coverage Policies by Payer Table 3. Coverage Clinical Scenarios by Private Payer and Medicare We found wide variation in how payers structured their policies—that is, whether the policy focused on the technology generally or on a
Joyce Y. Wong and Vernon K. Sondak
than 1% of cases. It exhibits unique clinical characteristics, occurring more frequently in men, elderly patients, and the head and neck region, and tends to present with thicker tumors. Both pure and mixed desmoplastic variants are described. Some